article thumbnail

Researchers invent self-powered drug delivery system

Medical Xpress

at Northwestern University—has developed novel technology with the potential to change the future of drug delivery. A team of scientists—led by Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D., at Shirley Ryan AbilityLab and John Rogers, Ph.D.,

article thumbnail

Intranasal Therapeutics and Drug Delivery Systems: The Perfect Alternative to Conventional Route of Administration

Roots Analysis

Stakeholders Involved in intranasal therapeutics and drug delivery domain. Based on our research maximum number of players are located in North America (80%), followed by Europe and Asia-Pacific & RoW (5%, each). Intranasal Therapeutics and Drug Delivery Systems. Our Social Media Platform. Web: [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Global Transdermal Drug Delivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com

BioTech 365

Global Transdermal Drug Delivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com Global Transdermal Drug Delivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 … Continue (..)

article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

In 1974, Dr. Robert Langer was part of the first cohort of researchers to begin nanoparticle research , as his lab at Cornell University developed tiny particles to deliver large molecules for angiogenesis. The next wave came from early research into liposomes and lipid nanoparticles, both of which are used for drug delivery.

article thumbnail

New drug carrier systems

Scienmag

University of Delaware researchers advance drug delivery systems to treat connective tissue disorders Credit: Graphic illustration by Jeffrey C.

article thumbnail

Researchers develop temperature-sensitive amyloid fibrils for therapy

BioPharma Reporter

In a promising advancement, scientists from the University of North Carolina at Chapel Hill and Emory University have developed a novel drug delivery system using synthetic amyloid beta (AÎ) peptides.

article thumbnail

Ceapro and McMaster extend partnership to develop Covid-19 therapy

Pharmaceutical Technology

Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects.